Literature DB >> 22913147

From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.

Y Wang1, J Li, J Chen, L Liu, Z Peng, J Ding, K Ding.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive tumor with poor prognosis. Understanding molecular changes in hepatocellular carcinoma should improve identification of risk factors in molecular subtypes and provide potential targets for early detection and therapy. AIM: The present study aimed to analyze the molecular mechanism of the transition from hepatitis C virus (HCV) induced cirrhosis to HCV induced HCC using microarray analysis combined with bioinformatics techniques. METHODS, To accomplish this, we performed the differential coexpression analysis of hepatic gene expression in samples of HCV-cirrhotic patients with and without HCC. Total 465 genes were identified and some of them were used to construct a regulatory network.
RESULTS: Our analysis indicated that several differentially co-express genes might play crucial roles in HCC development, including NA3C2, AHR, MYC, FOXO1 and FOSB. Further analysis predicted these genes might be involved in HCC through pathways of "ribosome", "steroid biosynthesis", "spliceosome" and so on. Moreover, these genes may serve as potential therapeutic targets for the treatment of HCC.
CONCLUSIONS: In conclusion, our findings confirm the presence of multiple molecular alterations during HCV-infected HCC hepatocarcinogenesis and indicate the possibility for identifying prognostic factors associated with HCC progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913147

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  AhR expression is increased in hepatocellular carcinoma.

Authors:  Ziyu Liu; Xing'an Wu; Fanglin Zhang; Lurong Han; Guoqiang Bao; Xianli He; Zhikai Xu
Journal:  J Mol Histol       Date:  2013-04-02       Impact factor: 2.611

Review 2.  FOXO1: Another avenue for treating digestive malignancy?

Authors:  Feiyu Shi; Tian Li; Zhi Liu; Kai Qu; Chengxin Shi; Yaguang Li; Qian Qin; Liang Cheng; Xin Jin; Tianyu Yu; Wencheng Di; Jianwen Que; Hongping Xia; Junjun She
Journal:  Semin Cancer Biol       Date:  2017-09-28       Impact factor: 15.707

3.  Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis.

Authors:  Sumei Wang; Zuoli Song; Bing Tan; Jinjuan Zhang; Jiandong Zhang; Shuye Liu
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

4.  HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis.

Authors:  Erica Silberstein; Laura Ulitzky; Livia Alves Lima; Nicoleta Cehan; Andréa Teixeira-Carvalho; Philippe Roingeard; Deborah R Taylor
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.